This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Advancell Diagnosztika Kft.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: György Várady: Innovator in Biomarker Determination
Introduction
György Várady is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of biomarker determination, particularly in the context of erythrocyte membrane proteins. His innovative work has the potential to enhance diagnostic capabilities in medical laboratories.
Latest Patents
Várady holds a patent for the invention titled "Quantitative determination of biomarkers in the erythrocyte membrane." This invention focuses on the quantitative expression of plasma membrane proteins as biomarkers in erythrocytes. The patent describes simple, quantitative assay platforms that can be utilized in most diagnostic laboratories. These platforms enable personalized, quantitative tests for the direct expression levels of a wide range of membrane proteins from small volume blood samples. Furthermore, they connect these levels to individual genetic variability, disease conditions, disease stages, complications, treatment protocols, pharmacological responses, and toxic side effects.
Career Highlights
György Várady is associated with Advancell Diagnosztika Kft., where he continues to develop and refine his innovative technologies. His work is instrumental in advancing the field of diagnostics and personalized medicine.
Collaborations
Várady collaborates with esteemed colleagues, including Balázs Sarkadi and Ildikó Kasza. Their combined expertise contributes to the success of their projects and the advancement of diagnostic technologies.
Conclusion
György Várady's contributions to the field of biomarker determination exemplify the impact of innovation in medical diagnostics. His work not only enhances laboratory capabilities but also paves the way for personalized medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile